Frazier Life Sciences XI, L.P.
Frazier Life Sciences XI, L.P. is a venture capital fund based in Menlo Park, California. According to its most recent Form D, filed Mar 18, 2022, it has sold $960,000,000 of interests to 98 investors since its first sale in Mar 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Patrick Heron; James Topper; Daniel Estes.
- Total raised
- $960,000,000Cumulative sales reported on Form D
- Investors
- 98
- First sale
- Mar 15, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Patrick Heron; James Topper; Daniel Estes
- Latest Form D
- Mar 18, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Frazier Life Sciences XI, L.P.
What is the minimum investment for Frazier Life Sciences XI, L.P.?
Frazier Life Sciences XI, L.P.'s latest Form D, filed Mar 18, 2022, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Frazier Life Sciences XI, L.P.?
Frazier Life Sciences XI, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Frazier Life Sciences XI, L.P. raised?
Frazier Life Sciences XI, L.P. reports $960,000,000 sold from 98 investors on its Form D filed Mar 18, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is Frazier Life Sciences XI, L.P. based?
Frazier Life Sciences XI, L.P. is based in Menlo Park, California.
When did Frazier Life Sciences XI, L.P. launch?
Frazier Life Sciences XI, L.P. reports its first sale in Mar 2022.
Size compared with every venture capital fund
Raised more than 99% of the 2,222 venture capital funds based in California, and more than 100% of all 14,829 that report sales.